Ramakrishnan Rajagopalan

Ramakrishnan Rajagopalan

Auto-generated profile, based on publicly available information

Ramakrishnan Rajagopalan

Division of Genomic Diagnostics, Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
RSRicha Saxena
Richa Saxena
CEClara C. Elbers
Clara C. Elbers
YGYiran Guo
Yiran Guo
IPInga Peter
Inga Peter
TGTom R. Gaunt
Tom R. Gaunt
BKBrendan J. Keating
Brendan J. Keating

1 November 2012 in The American Journal of Human Genetics
Verified
Journal Article
Open access
FAFolkert W. Asselbergs
Folkert W. Asselbergs
YGYiran Guo
Yiran Guo
EIErik P.A. van Iperen
Erik P.A. van Iperen
SSSuthesh Sivapalaratnam
Suthesh Sivapalaratnam
VTVinicius Tragante
Vinicius Tragante
FDFotios Drenos
Fotios Drenos
Genome-wide association studies (GWASs) have identified many SNPs underlying variations in plasma-lipid levels. We explore whether additional loci associated with plasma-lipid phenotypes, such as high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TGs), can be identified by a dense gene-centric approach. Our meta-analysis of 32 studies in 66,240 individuals of European ancestry was based on the custom ∼50,000 SNP genotyping array (the ITMAT-Broad-CARe array) covering ∼2,000 candidate genes. SNP-lipid associations were replicated either in a cohort comprising an additional 24,736 samples or within the Global Lipid Genetic Consortium. We identified four, six, ten, and four unreported SNPs in established lipid genes for HDL-C, LDL-C, TC, and TGs, respectively. We also identified several lipid-related SNPs in previously unreported genes: DGAT2, HCAR2, GPIHBP1, PPARG, and FTO for HDL-C; SOCS3, APOH, SPTY2D1, BRCA2, and VLDLR for LDL-C; SOCS3, UGT1A1, BRCA2, UBE3B, FCGR2A, CHUK, and INSIG2 for TC; and SERPINF2, C4B, GCK, GATA4, INSR, and LPAL2 for TGs. The proportion of explained phenotypic variance in the subset of studies providing individual-level data was 9.9% for HDL-C, 9.5% for LDL-C, 10.3% for TC, and 8.0% for TGs. This large meta-analysis of lipid phenotypes with the use of a dense gene-centric approach identified multiple SNPs not previously described in established lipid genes and several previously unknown loci. The explained phenotypic variance from this approach was comparable to that from a meta-analysis of GWAS data, suggesting that a focused genotyping approach can further increase the understanding of heritability of plasma lipids.

1 July 2017 in Immunobiology
Verified
Journal Article
Closed access
ELEmily B. Lurier
Emily B. Lurier
DDDonald Dalton
Donald Dalton
WDWill Dampier
Will Dampier
PRPichai Raman
Pichai Raman
SNSina Nassiri
Sina Nassiri
KSKara L. Spiller
Kara L. Spiller

4 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MLMichal Levy-Sakin
Michal Levy-Sakin
SPSteven Pastor
Steven Pastor
YMYulia Mostovoy
Yulia Mostovoy
LLLe Li
Le Li
ALAlden K. Y. Leung
Alden K. Y. Leung
PKPui-Yan Kwok
Pui-Yan Kwok
Large structural variants (SVs) in the human genome are difficult to detect and study by conventional sequencing technologies. With long-range genome analysis platforms, such as optical mapping, one can identify large SVs (>2 kb) across the genome in one experiment. Analyzing optical genome maps of 154 individuals from the 26 populations sequenced in the 1000 Genomes Project, we find that phylogenetic population patterns of large SVs are similar to those of single nucleotide variations in 86% of the human genome, while ~2% of the genome has high structural complexity. We are able to characterize SVs in many intractable regions of the genome, including segmental duplications and subtelomeric, pericentromeric, and acrocentric areas. In addition, we discover ~60 Mb of non-redundant genome content missing in the reference genome sequence assembly. Our results highlight the need for a comprehensive set of alternate haplotypes from different populations to represent SV patterns in the genome.

2 March 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KIKosuke Izumi
Kosuke Izumi
RNRyuichiro Nakato
Ryuichiro Nakato
ZZZhe Zhang
Zhe Zhang
AEAndrew C Edmondson
Andrew C Edmondson
SNSarah Noon
Sarah Noon
IKIan D Krantz
Ian D Krantz
Transcriptional elongation is critical for gene expression regulation during embryogenesis. The super elongation complex (SEC) governs this process by mobilizing paused RNA polymerase II (RNAP2). Using exome sequencing, we discovered missense mutations in AFF4, a core component of the SEC, in three unrelated probands with a new syndrome that phenotypically overlaps Cornelia de Lange syndrome (CdLS) that we have named CHOPS syndrome (C for cognitive impairment and coarse facies, H for heart defects, O for obesity, P for pulmonary involvement and S for short stature and skeletal dysplasia). Transcriptome and chromatin immunoprecipitation sequencing (ChIP-seq) analyses demonstrated similar alterations of genome-wide binding of AFF4, cohesin and RNAP2 in CdLS and CHOPS syndrome. Direct molecular interaction of the SEC, cohesin and RNAP2 was demonstrated. These data support a common molecular pathogenesis for CHOPS syndrome and CdLS caused by disturbance of transcriptional elongation due to alterations in genome-wide binding of AFF4 and cohesin.

25 July 2019 in Human Mutation
Verified
Journal Article
Open access
PDF file
MGMelissa A. Gilbert
Melissa A. Gilbert
RBRobert C. Bauer
Robert C. Bauer
RRRamakrishnan Rajagopalan
Ramakrishnan Rajagopalan
CGChristopher M. Grochowski
Christopher M. Grochowski
GCGrace Chao
Grace Chao
NSNancy B. Spinner
Nancy B. Spinner
Alagille syndrome is an autosomal dominant disease with a known molecular etiology of dysfunctional Notch signaling caused primarily by pathogenic variants in JAGGED1 (JAG1), but also by variants in NOTCH2. The majority of JAG1 variants result in loss of function, however disease has also been attributed to lesser understood missense variants. Conversely, the majority of NOTCH2 variants are missense, though fewer of these variants have been described. Additionally, there is a small group of patients with a clear clinical phenotype in the absence of a pathogenic variant. Here, we catalog our single‐center study, which includes 401 probands and 111 affected family members amassed over a 27‐year period, to provide updated mutation frequencies in JAG1 and NOTCH2 as well as functional validation of nine missense variants. Combining our cohort of 86 novel JAG1 and three novel NOTCH2 variants with previously published data (totaling 713 variants), we present the most comprehensive pathogenic variant overview for Alagille syndrome. Using this dataset, we developed new guidance to help with the classification of JAG1 missense variants. Finally, we report clinically‐consistent cases for which a molecular etiology has not been identified and discuss the potential for next generation sequencing methodologies in novel variant discovery.